Literature DB >> 3456003

Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence.

K Blomberg, C Granberg, I Hemmilä, T Lövgren.   

Abstract

The use of a new marker for labelling cells used as targets for natural killer cells is described. The human erythroleukaemic cell line K-562 was used as target. The cells were labelled with europium diethylenetriaminopentaacetate (EuDTPA) chelates. The detection of the released marker is based on time-resolved fluorometry. The results obtained show that the method is sensitive, specific and rapid. The high specific activity of the marker and the sensitivity of the detection apparatus result in numeric values (counts per second) which are 10-20 times higher than the values (counts per minute) obtained with 51chromium. In comparison with 51chromium release assay the labelling of target cells is less time consuming, the marker release more rapid and the detection time of released marker only 1 second per tube. The use of this non-radioactive marker is an alternative way of measuring natural killer cell mediated cytolysis of target cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3456003     DOI: 10.1016/0022-1759(86)90457-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  17 in total

1.  Evaluation of natural killer cell activity.

Authors:  J H Cox; M deSouza
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

2.  Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma.

Authors:  Smita K Nair; Timothy Driscoll; David Boczkowski; Robert Schmittling; Renee Reynolds; Laura A Johnson; Gerald Grant; Herbert Fuchs; Darell D Bigner; John H Sampson; Sridharan Gururangan; Duane A Mitchell
Journal:  J Neurooncol       Date:  2015-08-27       Impact factor: 4.130

3.  Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.

Authors:  Henry Ogbomo; Janina Geiler; Anke Leutz; Kristina von Kietzell; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-10-08       Impact factor: 3.402

4.  The relationship between the frequency of the common cold and the activities of natural killer cells.

Authors:  M Xu; T Muto; T Yabe; F Nagao; Y Fukuwatart; K Okumura
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

5.  Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma.

Authors:  P von Zons; P Crowley-Nowick; D Friberg; M Bell; U Koldovsky; T L Whiteside
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs.

Authors:  Michael C Brown; Eda K Holl; David Boczkowski; Elena Dobrikova; Mubeen Mosaheb; Vidya Chandramohan; Darell D Bigner; Matthias Gromeier; Smita K Nair
Journal:  Sci Transl Med       Date:  2017-09-20       Impact factor: 17.956

Review 7.  New flow cytometric assays for monitoring cell-mediated cytotoxicity.

Authors:  Liubov Zaritskaya; Michael R Shurin; Thomas J Sayers; Anatoli M Malyguine
Journal:  Expert Rev Vaccines       Date:  2010-06       Impact factor: 5.217

8.  Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.

Authors:  Smita K Nair; Gabriel De Leon; David Boczkowski; Robert Schmittling; Weihua Xie; Janet Staats; Rebecca Liu; Laura A Johnson; Kent Weinhold; Gary E Archer; John H Sampson; Duane A Mitchell
Journal:  Clin Cancer Res       Date:  2014-03-21       Impact factor: 12.531

9.  A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay.

Authors:  G G Kim; V S Donnenberg; A D Donnenberg; W Gooding; T L Whiteside
Journal:  J Immunol Methods       Date:  2007-06-28       Impact factor: 2.303

10.  Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides.

Authors:  S Zhang; F Helling; K O Lloyd; P O Livingston
Journal:  Cancer Immunol Immunother       Date:  1995-02       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.